Methotrexate toxicity in a patient receiving trimethoprim-sulfamethoxazole.

Abstract

A 61-year-old patient with rheumatoid arthritis receiving treatment with methotrexate developed bone marrow hypoplasia after treatment with trimethoprim-sulfamethoxazole. The bone marrow recovered after stopping methotrexate.